Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock.
Mathew R, Di Santo P, Jung RG, Marbach JA, Hutson J, Simard T, Ramirez FD, Harnett DT, Merdad A, Almufleh A, Weng W, Abdel-Razek O, Fernando SM, Kyeremanteng K, Bernick J, Wells GA, Chan V, Froeschl M, Labinaz M, Le May MR, Russo JJ, Hibbert B. Mathew R, et al. N Engl J Med. 2021 Aug 5;385(6):516-525. doi: 10.1056/NEJMoa2026845. N Engl J Med. 2021. PMID: 34347952 Clinical Trial.
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary intervention.
Jung RG, Simard T, Di Santo P, Dhaliwal S, Sypkes C, Duchez AC, Moreland R, Taylor K, Parlow S, Visintini S, Labinaz A, Marbach J, Sarathy K, Bernick J, Joseph J, Boland P, Abdel-Razek O, Harnett DT, Ramirez FD, Hibbert B. Jung RG, et al. Thromb Res. 2020 Jul;191:125-133. doi: 10.1016/j.thromres.2020.04.025. Epub 2020 Apr 24. Thromb Res. 2020. PMID: 32447094
Impact of baseline beta-blocker use on inotrope response and clinical outcomes in cardiogenic shock: a subgroup analysis of the DOREMI trial.
Di Santo P, Mathew R, Jung RG, Simard T, Skanes S, Mao B, Ramirez FD, Marbach JA, Abdel-Razek O, Motazedian P, Parlow S, Boczar KE, D'Egidio G, Hawken S, Bernick J, Wells GA, Dick A, So DY, Glover C, Russo JJ, McGuinty C, Hibbert B; CAPITAL DOREMI investigators. Di Santo P, et al. Crit Care. 2021 Aug 10;25(1):289. doi: 10.1186/s13054-021-03706-2. Crit Care. 2021. PMID: 34376218 Free PMC article. Clinical Trial.
The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial.
Parlow S, Di Santo P, Mathew R, Jung RG, Simard T, Gillmore T, Mao B, Abdel-Razek O, Ramirez FD, Marbach JA, Dick A, Glover C, Russo JJ, Froeschl M, Labinaz M, Fernando SM, Hibbert B; CAPITAL DOREMI investigators. Parlow S, et al. Eur Heart J Acute Cardiovasc Care. 2021 Oct 1;10(7):712-720. doi: 10.1093/ehjacc/zuab052. Eur Heart J Acute Cardiovasc Care. 2021. PMID: 34382063 Clinical Trial.
Implications of Myocardial Infarction on Management and Outcome in Cardiogenic Shock.
Jung RG, Di Santo P, Mathew R, Abdel-Razek O, Parlow S, Simard T, Marbach JA, Gillmore T, Mao B, Bernick J, Theriault-Lauzier P, Fu A, Lau L, Motazedian P, Russo JJ, Labinaz M, Hibbert B. Jung RG, et al. J Am Heart Assoc. 2021 Nov 2;10(21):e021570. doi: 10.1161/JAHA.121.021570. Epub 2021 Oct 29. J Am Heart Assoc. 2021. PMID: 34713704 Free PMC article. Clinical Trial.
Modifiable Risk Factors and Residual Risk Following Coronary Revascularization: Insights From a Regionalized Dedicated Follow-Up Clinic.
Simard T, Jung RG, Di Santo P, Harnett DT, Abdel-Razek O, Ramirez FD, Motazedian P, Parlow S, Labinaz A, Moreland R, Marbach J, Poulin A, Levi A, Majeed K, Boland P, Couture E, Sarathy K, Promislow S, Russo JJ, Chong AY, So D, Froeschl M, Dick A, Labinaz M, Le May M, Holmes DR Jr, Hibbert B. Simard T, et al. Mayo Clin Proc Innov Qual Outcomes. 2021 Dec 4;5(6):1138-1152. doi: 10.1016/j.mayocpiqo.2021.09.001. eCollection 2021 Dec. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34934904 Free PMC article.
Safety of same-day discharge in patients with left main percutaneous intervention.
Abdel-Razek O, Jung Y, Jung R, Skanes S, Dhaliwal S, Stotts C, Di Santo P, Goh CY, Verreault-Julien L, Visintini S, Bradley J, Simard T, Ramirez FD, Russo JJ, Froeschl M, Labinaz M, Hibbert B. Abdel-Razek O, et al. Coron Artery Dis. 2022 Aug 1;33(5):415-418. doi: 10.1097/MCA.0000000000001121. Epub 2022 Apr 27. Coron Artery Dis. 2022. PMID: 35170549 Free PMC article. No abstract available.
Significant Valvular Dysfunction and Outcomes in Cardiogenic Shock: Insights From the Randomized DOREMI Trial.
Parlow S, Weng W, Di Santo P, Jung RG, Lepage-Ratte MF, Motazedian P, Prosperi-Porta G, Abdel-Razek O, Simard T, Chan V, Labinaz M, Froeschl M, Mathew R, Hibbert B; CAPITAL DOREMI Investigators. Parlow S, et al. Can J Cardiol. 2022 Aug;38(8):1211-1219. doi: 10.1016/j.cjca.2022.04.004. Epub 2022 Apr 14. Can J Cardiol. 2022. PMID: 35430192 Clinical Trial.
44 results